Marian Filo       

Latest Citigroup Fdg Stock Trade

AMAG Pharmaceuticals' Ferumoxytol meets Phase III clinical trial end point.

• 20-year power purchase agreement (PPA) with Nevada Power Company
• Large generation interconnection (LGIA) for up to 75 MW approved
• Environmental assessment approved (FONSI)
• Company is well funded
• Well field development ongoing
• Ormat Technologies, EPC contract: fixed price, guaranteed completion of power plant

Geothermal power benefits:

• Geothermal is an economically-viable source of energy
• Geothermal is readily available
• Geothermal power plants provide reliable base load electricity
• Geothermal energy use relies on proven technology with a long operating life
• Geothermal benefits from incentives such as tax legislation and regional renewable energy targets.

BusinessWeek Rankings

BusinessWeek 50

2008   #49

2006   #45

BusinessWeek Rankings

Best Places to
Launch a Career

2007   #56

There are few sectors more maligned in 2008 than the healthcare group. The Morgan Stanley Healthcare Providers Index (HMO) has plunged more than 43% since January, compared to the 15% year-to-date loss in the S&P 500 Index (SPX). Even financial stocks, plagued by daily reports on the global credit crisis, are faring better, with the AMEX Select Financial Services Index (IXM) dropping 34% on a year-to-date basis. What's more, with a heavy bout of selling taking hold of the market on Friday, the HMO tagged a new multi-year low by breaking below long-term psychological support at the 1,200 level.

One member of the HMO that is particularly poised to suffer from an unwinding of heavy-handed bullish sentiment is Aetna (AET). The shares are off more than 37% in 2008. The security has quickly outpaced resistance at its declining 10-week and 20-week moving averages, breaking below key round-number support at the 40 level in early July. Furthermore, AET is now faced with short-term resistance in the 37 area - site of technical turbulence in September 2007.

On the sentiment front, the situation in the options pits may appear complacent, but the open interest configuration tells a different story. The current Schaeffer's put/call open interest ratio (SOIR) for AET rests at 0.66 in the middle of its annual range, suggesting a nonchalance from the speculative options crowd that is dangerous given the stock's technical troubles. Furthermore, peak July call open interest resides at the deep out-of-the-money 45 strike, totaling roughly 13,000 contracts.

On the put side of the coin, peak July put open interest resides at the in-the-money 40 strike, numbering nearly 7,000 contracts, with another 6,000 puts at the overhead July 45 strike. Below AET, there is a mere 3,500 puts at the 35 strike. This skew toward in-the-money puts indicates that investors do not expect AET to fall much further.

Elsewhere, Zacks reports that 10 of the 13 analysts following the shares rate them a "buy" or better. Downgrades could create additional selling pressure for AET, forcing the shares even lower.

Option players should consider an in-the-money (40 strike) intermediate-term put option – the August put (premium is 11% of the stock price) or October put (premium is 13.5% of the stock price) - to take advantage of this opportunity that is attractive from our Expectational Analysis ® methodology perspective.